Horizon Discovery (Cambridge) Limited
GPTKB entity
Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_PerkinElmer_in_2020
|
| gptkbp:awards |
Cambridge Business Awards 2019
Best_Biotechnology_Company_2018 |
| gptkbp:collaborations |
Partnership_with_Harvard_University
Partnership_with_MIT Partnership_with_Stanford_University Partnership_with_Yale_University Partnership_with_the_University_of_Cambridge |
| gptkbp:focus |
Precision medicine
Therapeutic development Genetic research |
| gptkbp:founded |
2007
|
| gptkbp:founder |
gptkb:Darrin_Disley
|
| gptkbp:headquarters |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Horizon Discovery (Cambridge) Limited
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:investmentFocus |
Institutional investors
Publicly_traded_on_the_London_Stock_Exchange |
| gptkbp:keyPeople |
gptkb:David_H._Smith
gptkb:Katherine_Stowe gptkb:Darrin_Disley |
| gptkbp:market |
Global biotechnology market
Pharmaceutical market Clinical research market Life sciences market Research and development market |
| gptkbp:partnerships |
Academic partnerships
Collaborations with pharmaceutical companies |
| gptkbp:products |
CRISPR technology
Cell line models Gene_editing_tools |
| gptkbp:research_focus |
Cell biology
Genetic disorders Oncology Drug discovery Biomarker_development |
| gptkbp:services |
Genetic engineering
Cell line development Gene_editing |
| gptkbp:subsidiary |
gptkb:Horizon_Discovery_(Asia)_Ltd.
gptkb:Horizon_Discovery_Inc. gptkb:Horizon_Discovery_(US)_Inc. |
| gptkbp:technology |
CRISPR-Cas9 technology
Cell engineering technology Synthetic biology technology Gene_editing_technology Genome_editing_technology |
| gptkbp:website |
www.horizondiscovery.com
|